Spark Investment Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Spark Investment Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20,670	Closed	-$207K	–	918
2015 Q4	$207K	Buy	+20,670	New	+$215K	0.03%	576
2014 Q2	–	Sell	-1,578	Closed	-$176K	–	821
2014 Q1	$176K	Sell	1,578 -222	-12%	-$15.6K	0.03%	546
2013 Q4	$77K	Sell	1,800 -1,389	-44%	-$65.2K	0.01%	580
2013 Q3	$190K	Buy	+3,189	New	+$167K	0.04%	456

Other funds holding TBRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Spark Investment Management's TBRA Position: Q1 2016 in Review

Spark Investment Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q1 2016, closing a stake of 20,670 shares — an estimated $207K sold.

Spark Investment Management first reported a position in TBRA in Q3 2013 and held it in 4 quarters. The position peaked at $207K in Q4 2015. 46 funds tracked by Wall St. Rank hold TBRA as of Q1 2016.

Spark Investment Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Spark Investment Management sold 20,670 Tobira Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $207K.
Spark Investment Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 4 quarters.
Spark Investment Management's Tobira Therapeutics, Inc. Common Stock position peaked at $207K in Q4 2015.
46 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.